Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1999
06/02/1999EP0918866A1 Anti-herpesviral agent
06/02/1999EP0918865A1 Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines
06/02/1999EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE
06/02/1999EP0918863A1 Frozen food product containing heat stable antifreeze protein
06/02/1999EP0918862A2 G protein signal transduction in plants
06/02/1999EP0918861A1 Treatment of human cancers with an adenovirus vector containing an interferon consensus gene
06/02/1999EP0918860A2 Tumor necrosis factor-related polypeptide
06/02/1999EP0918859A1 Testis-specific insulin homolog polypeptides
06/02/1999EP0918858A1 Common gamma chain blocking agents
06/02/1999EP0918857A1 Human induced tumor protein
06/02/1999EP0918856A2 Two human nsp-like proteins
06/02/1999EP0918855A1 Polycystic kidney disease gene
06/02/1999EP0918854A1 $i(M. TUBERCULOSIS) COMPLEX MEMBERS MYCOBACTERIA SPECIFIC NUCLEIC ACID FRAGMENTS AND THEIR APPLICATIONS FOR THE DETECTION AND DIFFERENTIAL DIAGNOSIS OF $i(M. TUBERCULOSIS) COMPLEX MEMBERS
06/02/1999EP0918853A2 Antisense rna with a secondary structure
06/02/1999EP0918852A1 Probe for analysis of nucleic acids
06/02/1999EP0918851A2 Expression system for altered expression levels
06/02/1999EP0918849A1 Transgenic plant cells and plants with modified acetyl-coa formation
06/02/1999EP0918848A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
06/02/1999EP0918845A1 Cleavable signal element device and method
06/02/1999EP0918797A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH $g(a)4$g(b)7 INTEGRIN
06/02/1999EP0918796A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
06/02/1999EP0918794A2 Uses for wnt polypeptides
06/02/1999EP0918790A1 Polycationic sterol derivatives as transfection agents
06/02/1999EP0918788A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer
06/02/1999EP0918787A1 Compositions and methods for antisense inhibition of protein translation
06/02/1999EP0918786A1 Nuclease protection assays
06/02/1999EP0918785A1 Cellular injury response element and uses thereof
06/02/1999EP0918540A1 Intradermal bovine polynucleotide vaccine
06/02/1999EP0918530A1 Preparation of immunostimulating agents based on propionibacteria
06/02/1999EP0918528A1 Method for treating gastrointestinal damage
06/02/1999EP0918455A1 Galanin
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0837931A4 Method for expression and isolation of biologically active molecules in urine
06/02/1999EP0821619A4 Methods and apparatus for the generation of chemical libraries
06/02/1999EP0693084A4 Chimeric cytokine receptors in lymphocytes
06/02/1999EP0680513B1 Lysosomal targeting of immunogens
06/02/1999EP0646124B1 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor
06/02/1999EP0631631B1 A process for producing heme proteins
06/02/1999EP0576606B1 Residual protease-iii
06/02/1999EP0521873B1 Anticoagulant proteins
06/02/1999EP0506763B1 Site-specific recombination of dna in plant cells
06/02/1999DE19752700A1 1-Deoxy-D-xylulose-5-phosphate synthase protein and modulators
06/02/1999CN1218515A Use of mutation in gene for human G-protein 'beta' 3 sub-unit for diagnosing illnesses
06/02/1999CN1218513A Vectors based on recombinant defenctive viral genmoes, and their use in formulation of vaccines
06/02/1999CN1218512A Recombinant adenoviral vectors for human tumour gene therapy
06/02/1999CN1218511A Promotor
06/02/1999CN1218510A Production of apomictic seed
06/02/1999CN1218509A Improved barster gene
06/02/1999CN1218508A Biosynthesis method enabling preparation of cobalamins
06/02/1999CN1218408A Method of treatment
06/02/1999CN1218406A HLA-A2.1 binding peptides and their uses
06/02/1999CN1218112A Protein production process
06/02/1999CN1218110A Novel esterase and methods for production of optically active chroman compounds
06/02/1999CA2254949A1 Transgenic animal
06/02/1999CA2223075A1 Drug binding protein
06/01/1999US5908975 Accumulation of fructans in plants by targeted expression of bacterial levansucrase
06/01/1999US5908973 DNA encoding fruit-ripening-related proteins, DNA constructs, cells and plants derived therefrom
06/01/1999US5908972 Isolated spinach ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit .sup.ε N-methyltransferase and method of inactivating ribulose-1,5-bisphosphatase carboxylase/oxygenase large subunit .sup.ε N-methyltransferase activity
06/01/1999US5908971 Ripening
06/01/1999US5908970 Recombinant plant expressing non-competitively binding Bt insecticidal crystal proteins
06/01/1999US5908969 Method of detecting prions in a sample and transgenic animal used for same
06/01/1999US5908926 Immobilization; radiation
06/01/1999US5908924 Cloning and expression of the gene encoding thermoanaerobacter ethanolicus 39E secondary-alcohol dehydrogenase and enzyme biochemical characterization
06/01/1999US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
06/01/1999US5908868 Retinol derivatives useful for enhancing immune response
06/01/1999US5908845 Polyether nucleic acids
06/01/1999US5908839 Administering mixture of tyrosine kinase inhibitor and amino sterol
06/01/1999US5908831 Polypeptides
06/01/1999US5908827 Protein from urine named component B
06/01/1999US5908825 Dosage composition for nasal delivery and method of use of the same
06/01/1999US5908810 Method of improving the growth of crop plants which are resistant to glutamine synthetase inhibitors
06/01/1999US5908790 Methods for removing heavy metals from aqueous solutions and for analysis
06/01/1999US5908780 Cells transformed or transfected with HCMV US2 gene
06/01/1999US5908779 A mammalian cell containing a dna construct with a promoter, an antisense sequence and a cis-ribozyme; regulating gene expression and accumulating antisense rna in the nucleus; therapy and viricides
06/01/1999US5908778 Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof
06/01/1999US5908777 Lipidic vector for nucleic acid delivery
06/01/1999US5908772 Gene encoding lacto-N-biosidase
06/01/1999US5908771 Method for regeneration of salvia species
06/01/1999US5908768 Process for producing L-glutamic acid by fermentation with E. coli resistant to aspartic acid antimetabolite
06/01/1999US5908765 Producing bioactive natural molecules from microorganisms in environmental samples; isolating nucleic acid, inserting into donor liposomes, fusing with recipient protoplast producing recombinant microorganisms producing product
06/01/1999US5908764 Genetically engineered organism which concurrently expresses erythromycin and heterologous oxygen-binding protein
06/01/1999US5908763 Granulocyte-macrophage colony stimulating factor; for myelo-suppression caused by cancer treatments of irradiation and chemotherapy
06/01/1999US5908760 α-1,4-glucan lyase from a fungus, its purification gene cloning and expression in microorganisms
06/01/1999US5908756 Protein inhibitor of neuronal nitric oxide synthase
06/01/1999US5908755 Complexing single-stranded polynucleotide with primer
06/01/1999US5908753 Transformation of Candida albicans by electroporation
06/01/1999US5908747 Isolated wildtype gene in nuclear chromosomes coding a polypeptide that induces homologous recombination in mitochondria; aging resistance agent
06/01/1999US5908744 Detecting Mycobacterium tuberculosis by nucleic acid sequence amplification
06/01/1999US5908743 Gag gene primers for the detection of HIV-1
06/01/1999US5908635 Method for the liposomal delivery of nucleic acids
06/01/1999US5908629 Polysaccharide-protein complex
06/01/1999US5908627 Antigen associated with Type I diabetes mellitus
06/01/1999US5908626 Genetic engineering
06/01/1999US5908623 Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
06/01/1999CA2251260A1 Escape mutant of the surface antigen of hepatitis b virus
06/01/1999CA2097698C Human dopamine d4 receptor and its uses
06/01/1999CA2079749C Silicon tetrahydrazide for purification of dna
06/01/1999CA2060372C Strand displacement amplification
06/01/1999CA1340577C Recombinant systems for expressions of cholera b-subunit with the aid of foreign promoters and/or leader peptides
05/1999
05/28/1999CA2219271A1 1-deoxy-d-xylulose 5-phosphate synthase, a process for identifying effectors of 1-deoxy-d-xylulose 5-phosphate synthase and effectors of 1-deoxy-d-xylulose 5-phosphate synthase